ArticleEthiopian journal of health sciences2025
Predictors of Complete Remission in Differentiated Thyroid Cancer: A Study from the Nuclear Medicine Department of Ibn Rochd Hospital in Casablanca, Morocco.
Article in Ethiopian journal of health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Differentiated thyroid cancers (DTCs) are the most common endocrine malignancies. Although they are generally associated with a favorable prognosis, some patients do not achieve complete remission after treatment. This study aimed to identify predictive factors for complete remission among Moroccan patients with DTCs. Patients and Methods: We retrospectively reviewed the medical records of patients diagnosed with DTCs between 2004 and 2012 and followed at the Nuclear Medicine Department of Ibn Rochd Hospital. Associations between complete remission and various epidemiological and histopathological factors were assessed using the chi-square test and logistic regression. Results: A total of 1,366 patients were included. The cohort comprised 89.6% females and 10.4% males, with a sex ratio of 8.5. The mean age at diagnosis was 44 years (range: 14-85 years), and the mean follow-up duration was 125 months. Logistic regression analysis identified the following as significant predictors of complete remission: female sex, age <55 years, papillary thyroid carcinoma, tumor size ≤4 cm, unilaterality, absence of extrathyroidal extension, absence of vascular invasion, undetectable postoperative thyroglobulin (TG) levels, and absence of local or distant involvement. Conclusion: Younger age, female sex, favorable histology, and limited tumor burden were associated with a higher likelihood of complete remission in Moroccan patients with DTCs. Identifying these factors is crucial for tailoring treatment strategies and optimizing follow-up, particularly for patients at higher risk of persistent or recurrent disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.